Tolerability ol epirubicin, oxaliplatin, and capecitabine chemotherapy in advanced esophagogastric cancer.

被引：0
|
作者：
Rigby, Christina [1 ]
Evans, Marion [1 ]
Chan, Kevin [1 ]
Spencer-Shaw, Andrea [1 ]
Owen-Holt, Vikki [1 ]
Mansoor, Wasat [1 ]
机构：
[1] Christie Hosp NHS Fdn Trust, Manchester, Lancs, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e15078
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15078
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer.
    Cunningham, David
    Okines, Alicia F. C.
    Ashley, Sue
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (09): : 858 - 859
  • [2] A restrospective analysis of toxicities encountered with palliative epirubicin, oxaliplatin, and capecitabine (EOX) chemotherapy for advanced esophagogastric cancer.
    Khakoo, Shelize Sadrudin
    Georgiou, Alexandros
    Waters, Justin S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [3] Epirubicin, Oxaliplatin & Capecitabine Combination for Untreated Advanced Esophagogastric Cancer
    Alam, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S466 - S467
  • [4] Capecitabine and oxaliplatin for advanced esophagogastric cancer
    Cunningham, David
    Starling, Naureen
    Rao, Sheela
    Iveson, Timothy
    Nicolson, Marianne
    Coxon, Fareeda
    Middleton, Gary
    Daniel, Francis
    Oates, Jacqueline
    Norman, Andrew Richard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (01): : 36 - 46
  • [5] Capecitabine and oxaliplatin for advanced esophagogastric cancer - Reply
    Perrotta, Silverio
    Della Ragione, Fulvio
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (18): : 1966 - 1966
  • [6] Capecitabine and oxaliplatin are effective treatments in advanced esophagogastric cancer
    [J]. Nature Clinical Practice Oncology, 2008, 5 (4): : 180 - 181
  • [7] Locally advanced gastric cancer treated with neoadjuvant chemotherapy: Epirubicin, oxaliplatin, and capecitabine (EOX)
    Pluschnig, U.
    Zacherl, J.
    Schoppmann, S.
    Raderer, M.
    Prager, G.
    Bartsch, R.
    Ba-Ssalamah, A.
    Lamm, W.
    Zielinski, C.
    Hejna, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [8] A randomized, multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3).
    Waddell, Tom Samuel
    Chau, Ian
    Barbachano, Yolanda
    de Castro, David Gonzalez
    Wotherspoon, Andrew
    Saffery, Claire
    Middleton, Gary William
    Wadsley, Jonathan
    Ferry, David Raymond
    Mansoor, Wasat
    Crosby, Tom David Lewis
    Coxon, Fareeda Y.
    Smith, David
    Waters, Justin S.
    Iveson, Timothy
    Falk, Stephen
    Slater, Sarah
    Okines, Alicia Frances Clare
    Cunningham, David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Perioperative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy in Locally Advanced Gastric Cancer: Safety and Feasibility in an Interim Survival Analysis
    Ostwal, Vikas
    Sahu, Arvind
    Ramaswamy, Anant
    Sirohi, Bhawna
    Bose, Subhadeep
    Talreja, Vikas
    Goel, Mahesh
    Patkar, Shraddha
    Desouza, Ashwin
    Shrikhande, Shailesh V.
    [J]. JOURNAL OF GASTRIC CANCER, 2017, 17 (01) : 21 - 32
  • [10] The Effect of Supplementary Omegaven® on the Clinical Outcome of Patients With Advanced Esophagogastric Adenocarcinoma Receiving Palliative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy: A Phase II clinical trial
    Eltweri, Amar M.
    Thomas, Anne L.
    Chung, Wen Y.
    Morgan, Bruno
    Thompson, John
    Dennison, Ashley R.
    Bowrey, David J.
    [J]. ANTICANCER RESEARCH, 2019, 39 (02) : 853 - 861
12345